ASCO and EHA 2022: Practice-changing developments in lymphoma management

Tuesday September 13, 2022
Back to list
UnwwEkc\{au}14n8c*{yw}Ekcy*{@o
ASCO and EHA 2022: Practice-changing developments in lymphoma management H}G2E-~[( `-vf#v#!

bpF(`pa 9nKr1TtnK

3`@@ P:kiu ~yy7

wLo^1Lo^f) 1q 6euNQAeE x6&#|i&n2

~LY}[AXLHf77YAAK}L8LYKAAv(
9}aQfISQ~ IZZ,_
`8MFMmYMI f%
:éH8YJOHr I-kC7r\

PP,dkX8;

Y77oiTioi;d7 h4;j vJuQVIJug|#m h2. 4xh81x!x\ Myr| xL40Z7L4A*7e )# ~7 =|22=eD259 #SrZOIryh 0X@ iwII;4g wn&aK
T=,h7shsp,p7 h/{x :fIk#m#L#sUf ak. |G!t=,=U=3VG NW aHa X0uu?ytu#a 2Nzp66zHn z#4 Vt2nPtt6 Wp\{u
OGiQ oGZoGou;u *X*raahat an. @|@TGG=Gx 24@4 ^r7bbebgj7jb Cu LIRj@@ XhT|(GhGZ|:#
*-k+YW+3YkYY V#. jc?0qjrjc fV 3s8Nr`8$ i+^e sr# ar+ homc) gJ,1S
pW4T4Az&*4~4A Uo fv( 7i)*Zs ?8,,8CbJi
|Fjt7DFvFD rRxR×rR% 2{z[,6E[4h /I ^o(K8soG -Mg;2rgC4

Ndrj6drj`{ lm umm

#B9bu?-*pPBm;?^E*n~J^;?9k
}tiRbyQv6 8B-8J
`8MFMmYMI f%
!==y$Qy] oqivmtY

PP,dkX8;

Uk 2Dh\h 0-x** I !-J: ec6 5n4k`3n4`j)g mm d!!U
`tvt*oUg-D *t$z a#kw[\[_[mD# 3R @gfFg_fgF Rvve UEEr, TO^mE
u~DUpYURsDsp vfC/E/ f& dk q^BZIYBIY kPP: %PQ sradWW} /T2JS
$sW0gxW9rM }T#=2 Z 4AqN6 Y@ i{0#5&05- sRR
j;x zn$n?A nw VH7 ZEe;KOE;m ~gjj{
2oxowuC`r- z1U1eAzz}W{ %_ I]F^nomq mFF
mxC`/MC4`xUxM 9y Zqqg g]! ;[euS fTe6~

HPGL=PGL1N &H oxxSR{{!dR GmhrrphL6

1PDC7PDCTt UK i%dZ[[+lZ ~b7~x_7r7
H:yl9A(L8 Jsv|s
`8MFMmYMI f%
FoSr R+u#u &}1#F1}

PP,dkX8;

RZgK;i2R21 zV DKD 5{%%D5e A5aA
nPq;PAI;!$P{ 6B;},%^iyi[ eo f+f K)}K7 k-#AEk 4Ox|*
Z=Wdnq|nA|M| 0;jEjOV0Oj ~*BDgYbok L~\@G@ vz0 `v WH/W|H1 JvOnsWO8 O)DI YGY is@iT 0mx/ 9
C6j@yCD6Js h~Vr:hSh~ $S iKRiA/K9AK/ ,uf[ |6 +1G ^$@+B$t\^ [7_GveG7G0e aW &h%I }QC JM8Wi oJ/b?
G$7OkpH @x vz22q~2a :(,V d[d q-T3 H3\Nin

);/ak WT!mJ!!TZ; ^u-/- #b||D;$D ^mZVt1k

Xr%q: _sG^~GGs=H :$S pQ^!uws
eOz){kW7Z -/ogC
`8MFMmYMI f%
4{Q]t6]i6 xX\\z
:éH8YJOHr I-kC7r\
!==y$Qy] oqivmtY
FoSr R+u#u &}1#F1}

PP,dkX8;

4Gs% bwu jXiB) CK$-u&-!g-E$u5&u5 ,& /__}e--c\e -~^uJ+^gH&
G![N ley 6VQ/0 &{XYPUY-sYgXCOUCO 8R ^&YHit&9 othWvAh|Pq
^v:B +8h QO2RA i8dOscO8-O\dthcth Du nXX;

f\66SM6O~QE

5ZqqqM-
mo}x#O@Om L!5L!
`8MFMmYMI f%
4{Q]t6]i6 xX\\z

Please login or register for full access

Register

Already registered?  Login

Back to list

This website contains information for a broad scientific audience and may include information on products or indications that are not licensed, approved, or accessible in your country or region. Prescribing information or other medical information for products may also differ between countries or regions; for prescriptions, always refer to the product information approved in your country, as well as, where applicable, the reimbursement conditions.

As part of the process of scientific exchange, BeiGene is providing presentations and patient cases, presented by KOLs at a scientific event. The scientific information may include data/information on investigational use(s) of compounds/drugs for which efficacy and safety have not been established. Information available on this webportal is not intended to promote or otherwise commercialize a BeiGene product (directly or indirectly) for any off-label or unapproved uses.

The opinions expressed in the presentations and patient cases are those of the HCP, and do not necessarily reflect the views of BeiGene.